Arcus Biosciences Market Sentiment

Arcus Biosciences Inc

RCUSNYSE

Trade with Public

$23.46

-0.29-1.22%

Dern. MÀJ: Oct 21, 10:00 AM

$24.05

0.301.26%

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

PRO

Pourquoi cela bouge-t-il ?:Arcus Biosciences shares are trading higher after the company announced new...

Arcus Biosciences Market Sentiment - Benzinga

Arcus Biosciences Market Sentiment

Market sentiment signals for Arcus Biosciences (RCUS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 17.1% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

20 analysts

Options Flow (P/C)

0.00

More calls — Bullish

1 calls · 0 puts

Avg Consensus PT

$37

+55.8%

Highest Price Target

$50

+113.1%

Truist Securities

Lowest Price Target

$14

-40.3%

Barclays

Short Interest

17.1%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	Truist Securities	Supawat Thongthip—	+74.8%	$40 → $41	Maintained	Buy
Oct 21, 2026	Wedbush	Robert Driscoll—	+108.9%	$43 → $49	Maintained	Outperform
Oct 16, 2026	William Blair	Alethia Young—	—	—	Initiate	Outperform
Oct 14, 2026	JP Morgan	Priyanka Grover—	+74.8%	$41	Initiate	Overweight
Sep 30, 2026	Wedbush	Robert Driscoll—	+83.3%	$43 → $43	Maintained	Outperform
Sep 16, 2026	TD Cowen	Tara Bancroft—	—	—	Initiate	Buy
Sep 8, 2026	Truist Securities	Supawat Thongthip—	+70.5%	$35 → $40	Maintained	Buy
Aug 6, 2026	Wells Fargo	Eva Fortea Verdejo—	+10.8%	$23 → $26	Maintained	Equal-Weight
Aug 6, 2026	Wedbush	Robert Driscoll—	+83.3%	$41 → $43	Maintained	Outperform
Jul 20, 2026	HC Wainwright & Co.	Emily Bodnar—	+91.8%	$32 → $45	Maintained	Buy
Jun 4, 2026	LifeSci Capital	Charles Zhu—	+96.1%	$46	Initiate	Outperform
May 18, 2026	Truist Securities	Supawat Thongthip—	+49.2%	$30 → $35	Assumes	Buy
May 11, 2026	Morgan Stanley	Terence Flynn—	-6.2%	$20 → $22	Maintained	Equal-Weight
May 7, 2026	Goldman Sachs	Richard Law—	+44.9%	$30 → $34	Maintained	Buy
Apr 2, 2026	Wedbush	Robert Driscoll—	+74.8%	$37 → $41	Maintained	Outperform
Mar 5, 2026	Citigroup	Yigal Nochomovitz—	+91.8%	$44 → $45	Maintained	Buy
Mar 2, 2026	Leerink Partners	Geoffrey Porges—	+108.9%	$36 → $49	Maintained	Outperform
Mar 2, 2026	HC Wainwright & Co.	Emily Bodnar—	+36.4%	$32 → $32	Maintained	Buy
Feb 12, 2026	Wells Fargo	Eva Fortea Verdejo—	-2.0%	$30 → $23	Downgrade	Overweight→Equal-Weight
Jan 13, 2026	Goldman Sachs	Richard Law—	+19.4%	$16 → $28	Upgrade	Neutral→Buy
Jan 8, 2026	Morgan Stanley	Terence Flynn—	-14.7%	$23 → $20	Downgrade	Overweight→Equal-Weight
Dec 12, 2025	HC Wainwright & Co.	Emily Bodnar—	+36.4%	$28 → $32	Maintained	Buy
Nov 28, 2025	B of A Securities	Jason Zemansky—	+10.8%	$17 → $26	Maintained	Neutral
Oct 30, 2025	Goldman Sachs	Salveen Richter—	-31.8%	$14 → $16	Maintained	Neutral
Oct 29, 2025	Citigroup	Yigal Nochomovitz—	+138.7%	$54 → $56	Maintained	Buy